Youth theatre in Toms River stages production of Gulliver's Travels narrative
The Tomsk Young Spectator Theater is set to host the premiere of the play 'His Name is Lemuel' on October 3 and 4. This captivating production, directed by Mikhail Zhigalov, offers a unique take on the classic tale of Gulliver's Travels, setting the story in a Russian setting.
The play explores the clash between Gulliver, a man not built for a certain kind of journey, and a society with its own rules, customs, and rituals. Gulliver, portrayed as a man not particularly strong in spirit, finds himself in an unfamiliar Russian environment, encountering characters like скоморохи and Baba Yaga, which introduce elements from Russian folklore.
Gulliver's behavior in the play is at odds with expectations in a Russian fairy tale, presenting a narrative that challenges traditional societal norms and expectations. The main theme of the play is the hero's self-identification among established ways of behavior.
The production is helmed by Dmitry Grebenshchikov, with Ivan Mashchev and costume designer Ekaterina Burimova contributing to the visual aspect of the play. The cast includes renowned artists such as Oleg Streletz, Olga Ulyanova, Alexandra Ukhman, Vyacheslav Ostwald, Ruslan Kostyurin, Alexander Chernikov, Vladislav Soroka, Timofey Abaskalov, Darya Avdyushina, Valeria Borodkina, Sofia Kulishina, and Olga Ryabova, who is a Merited Artist of Russia.
Ballet mistress Ekaterina Makarova is also working on the play, promising a blend of drama and ballet in this intriguing production. The play 'His Name is Lemuel' is based on Jonathan Swift's 'Gulliver's Travels,' offering a fresh perspective on the classic tale. Don't miss the opportunity to witness this thought-provoking play at the Tomsk Young Spectator Theater.
Read also:
- Sharply rising fatal accidents in Mainz 2025: A 144% surge in deaths - authorities plan to enhance safety for the elderly population
- Exploring the Digestive Benefits of Fermented Foods
- Senator Rasha Kelej welcomed Maldives First Lady at the seventh installment of the Merck Foundation's First Ladies Initiative Summit to discuss collaborative healthcare programs.
- Quarterly Review of the Biotechnology and Pharmaceutical Industries: A Look Back at Q2 2025
